BiotechTube
Access Vascular

Access Vascular

Billerica, United States· Est.
accessvascularinc.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $23M

Overview

Access Vascular is addressing a significant unmet need in vascular access by commercializing catheters made from a proprietary hydrophilic biomaterial, branded as MIMIX® technology. Its flagship products, HydroPICC® and HydroMID®, are designed to dramatically reduce thrombus accumulation compared to standard polyurethane catheters, aiming to lower complication rates, improve patient experience, and reduce hospital costs. The company is in the commercial stage, actively selling its FDA-cleared devices into the hospital market, supported by pre-clinical and initial clinical data.

HematologyVascular Access

Technology Platform

Proprietary hydrophilic biomaterial (MIMIX® technology) engineered into the bulk of catheters to reduce thrombus accumulation and related complications, without relying on coatings or surface modifications.

Funding History

2
Total raised:$23M
Series B$15M
Series A$8M

Opportunities

The massive vascular access device market is burdened by high complication costs, creating a strong value-based purchasing argument for superior technology.
The proprietary MIMIX platform is scalable to other catheter types (e.g., short peripherals, dialysis catheters), offering clear pipeline expansion opportunities.
The shift towards value-based care in healthcare aligns perfectly with a product designed to improve outcomes and reduce total cost of care.

Risk Factors

Commercial execution risk is high, as displacing entrenched, low-cost standard catheters requires convincing hospital systems to change practice.
While early data is promising, broader clinical evidence is needed to definitively prove superior outcomes and secure favorable reimbursement.
Large, well-funded competitors could respond aggressively with price cuts, improved products, or marketing campaigns.

Competitive Landscape

The vascular access market is dominated by large, established players like Becton Dickinson (BD), Teleflex, and ICU Medical, which offer a wide range of traditional polyurethane and silicone catheters. Competition also comes from companies using alternative strategies, such as antimicrobial- or antithrombotic-coated catheters. Access Vascular differentiates by using a bulk hydrophilic biomaterial rather than a surface coating, claiming more durable and inherent thromboresistance.

More companies in Small Molecule Drugs →More companies in United States →